feed,title,long_url,short_url
BioRxiv,"Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2",https://biorxiv.org/cgi/content/short/2022.02.27.482147v1?rss=1,https://bit.ly/36RxcG8
BioRxiv,An immunoPET probe to SARS-CoV-2 reveals early infection of the male genital tract in rhesus macaques,https://biorxiv.org/cgi/content/short/2022.02.25.481974v1?rss=1,https://bit.ly/3MmhG5s
BioRxiv,A strategy to optimize the peptide-based inhibitors against different mutants of the spike protein of SARS-CoV-2,https://biorxiv.org/cgi/content/short/2022.02.27.482153v1?rss=1,https://bit.ly/3HrUjDH
BioRxiv,Efficient Neutralization of SARS-CoV-2 Omicron and Other VOCs by a Broad Spectrum Antibody 8G3,https://biorxiv.org/cgi/content/short/2022.02.25.482049v1?rss=1,https://bit.ly/3hnKoVg
